# A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.

> **NCT01301092** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 30 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **BIOLOGICAL:** LY2189265

## Key facts

- **NCT ID:** NCT01301092
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301092, "A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01301092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*